Latest It Services News

Respiri Limited reports a standout December quarter marked by a 67% surge in patient program enrolments and robust revenue growth, bolstered by strategic acquisition synergies from Orb Health. The company is poised for further expansion in 2025 amid promising contract negotiations and evolving US healthcare reimbursement policies.

I Synergy Group Limited has reshaped its board with the resignation of Joshua Hunt, the appointment of Jiayi Yu as Non-Executive Director, and the promotion of Heng Jee Meng to Managing Director, signaling a renewed focus on shareholder value.

4DMedical has signed a landmark commercial agreement with Qscan Radiology Clinics, marking its first Australian contract to integrate both Pulmonary Function and Pulmonary Structure imaging products.

Coventry Group reports a slight dip in H1 FY25 sales but manages a modest EBITDA increase, buoyed by a successful ERP upgrade and strategic growth initiatives.

International Graphite advances its vision of a fully integrated graphite supply chain in Western Australia, securing significant government funding and delivering promising drilling and testwork results at its Springdale project.

Pacific Smiles Group reports robust patient fee growth of over 9% year-on-year and reaffirms FY25 guidance, while announcing a CFO change as Genesis Capital solidifies its majority stake.

BSA Limited reported a robust Q2 FY2025 with revenue up 10.7% and EBITDA surging 31.5%, underpinned by a key contract extension with nbn. The company has upgraded its full-year EBITDA guidance, signaling confidence in sustained profitability.

Aquirian’s subsidiary Western Energetics has secured a $20 million, three-year supply agreement with Mt Ida Goldmine, delivering innovative energetics and technology solutions that promise cost savings and environmental benefits.

Tower Limited has appointed CFO Paul Johnston as interim CEO following Blair Turnbull's resignation, with Deputy CFO Angus Shelton stepping in as interim CFO pending regulatory approval.

InhalerX Limited reported a negative cash flow for the December quarter despite securing a substantial $38.5 million funding facility aimed at advancing its clinical trials. The company has yet to draw on this facility, maintaining a cautious cash position as it progresses its drug development programs.

Vonex Limited reports solid operational improvements and customer satisfaction in Q2 FY25, while endorsing Maxo Telecommunications’ takeover offer and planning a $13 million capital raise to manage debt.

Vonex Limited reported a net cash inflow of $779,000 from operating activities in Q4 2024, maintaining a solid cash position despite accelerated debt repayments following a change of control.